The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Image provided by Pond Tech

Global climate change has become an increasingly important issue to tackle for both governments and the private sector. At the core of that hesitation is the problem of balancing environmental priorities with economic ones: How can economies built on fossil fuel transition to cleaner, more sustainable alternatives without triggering major disruptions to those same economies?

Pond Carbon Offers the Leading Scalable Algae-Based Carbon Capture Platform to Enter $6.7 Billion Carbon Market

As impressive as it is, cultivating enough algae to make a meaningful dent in carbon emissions has been challenging. Existing systems rely on large outdoor ponds that rely on natural sunlight and are exposed to multiple sources of contamination. 

In these outdoor systems, algae can only grow to depths of a few inches or so below the surface of the water. Such shallow growth means that constructing an algae farm large enough to capture the emissions of even a single factory would require thousands of acres of land. Even with enough land available, the algae that’s grown could be unusable in many applications because of the contamination that can exist in these outdoor systems.

Then, the algae that’s harvested from the tanks can be used to create a wide range of exciting and profitable products. Those algae-based products are where the other branches of Pond’s business model come in.

Pond Naturals — A Vertically Integrated Nutraceutical Supplier in the $417 Billion Global Market

The market for algae products is massive. With multiple strains boasting different but equally impressive benefits, the carbon-capturing plant is also a highly nutritious food source that can be turned into functional foods, health supplements, and other nutraceuticals.

Pond Naturals, the 2nd prong of the algae-based system, is focused on manufacturing and distributing algae-based nutraceuticals. After servicing industrial customers, Pond harvests the algae grown in those tanks and turns it into astaxanthin supplements, vegan-friendly high-protein powders and other consumer health products. 

Pond's vertically integrated model enables industries to monetize their waste emissions, reduce their carbon footprint and create sustainable products. 

Pond Biotech — Innovating in the $126 Billion Global Recombinant Protein Market

The final prong of Pond’s approach is its biotech solutions. Because algae boast such high amounts of protein and because it’s relatively easy to genetically modify, Pond’s algae platform can provide the raw materials to biopharmaceutical and biotech labs that need to develop protein-based diagnostics and therapeutics.

Unlike the mammalian cell cultures, researchers currently rely on to grow the proteins they use to make life-saving treatments, algae are easier and faster to grow. They can also be modified to express precisely the proteins researchers need for the diagnostic or therapeutic treatments they’re working on. Pond’s unique tank-growing platforms also provide the controlled-growth environment needed to produce safe, high-quality, genetically modified algae.

A recent agreement Pond struck with a Fortune 500 company is a prime example of how all these branches come together. The CAD $1 million ($794,270) deal is an early validator for this division.